Skip to main content
Patricia Walker, MD, Dermatology, Carpinteria, CA

PatriciaSueWalkerMD

Dermatology Carpinteria, CA

Physician

Dr. Walker is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Walker's full profile

Already have an account?

  • Office

    5565 Carpinteria Ave
    Suite 2
    Carpinteria, CA 93013
    Phone+1 805-745-1013
    Fax+1 805-566-0319

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterResidency, Dermatology, 1993 - 1997
  • University of Iowa Hospitals and Clinics
    University of Iowa Hospitals and ClinicsResidency, Dermatology, 1991 - 1993
  • University of Minnesota
    University of MinnesotaInternship, Internal Medicine, 1990 - 1991
  • University of Iowa Roy J. and Lucille A. Carver College of Medicine
    University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1990

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1998 - 2026
  • IA State Medical License
    IA State Medical License 1991 - 1999
  • American Board of Dermatology Dermatology

Awards, Honors, & Recognition

  • Fellow (FAAD) American Academy of Dermatology
  • Fellow (FASDS) American Society for Dermatologic Surgery

Publications & Presentations

PubMed

Press Mentions

  • Brickell Biotech Announces Positive Phase 2b Study Results for BBI-4000 (Sofpironium Bromide) in Subjects with Primary Axillary Hyperhidrosis
    Brickell Biotech Announces Positive Phase 2b Study Results for BBI-4000 (Sofpironium Bromide) in Subjects with Primary Axillary HyperhidrosisOctober 24th, 2017
  • Newly Published Data Reveal That Hyperhidrosis (Excessive Sweating) Is More Prevalent, Severe and Socially Debilitating Than Previously Reported
    Newly Published Data Reveal That Hyperhidrosis (Excessive Sweating) Is More Prevalent, Severe and Socially Debilitating Than Previously ReportedOctober 19th, 2016
  • BBI-4000 (Sofpironium Bromide) Demonstrates Promising Potential as a Safe and Effective First-Line Treatment for Excessive Underarm Sweating
    BBI-4000 (Sofpironium Bromide) Demonstrates Promising Potential as a Safe and Effective First-Line Treatment for Excessive Underarm SweatingMarch 7th, 2016
  • Join now to see all

Professional Memberships